abstract |
Compounds with the formula (I) that are useful for treating conditions or disorders that can be prevented or improved by histamine-3 receptor ligands are described. Pharmaceutical compositions comprising histamine-3 receptor ligands, methods for using said compounds and compositions, and a process for preparing compounds within the scope of formula (I) are also described. (See formula (I)). |